CurveBeam AI Future Growth
Future criteria checks 5/6
CurveBeam AI is forecast to grow earnings and revenue by 89.4% and 48.5% per annum respectively. EPS is expected to grow by 64.7% per annum. Return on equity is forecast to be -0.2% in 3 years.
Key information
89.4%
Earnings growth rate
64.7%
EPS growth rate
Medical Equipment earnings growth | 16.6% |
Revenue growth rate | 48.5% |
Future return on equity | -0.2% |
Analyst coverage | Low |
Last updated | 06 May 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 40 | -1 | -2 | -4 | 2 |
6/30/2025 | 24 | -12 | -6 | -11 | 2 |
6/30/2024 | 9 | -23 | -17 | -20 | 1 |
12/31/2023 | 9 | -57 | -26 | -26 | N/A |
9/30/2023 | 9 | -54 | -24 | -24 | N/A |
6/30/2023 | 8 | -51 | -23 | -22 | N/A |
3/31/2023 | 5 | -33 | -18 | -17 | N/A |
12/31/2022 | 1 | -14 | -13 | -13 | N/A |
9/30/2022 | 1 | -11 | -11 | -11 | N/A |
6/30/2022 | N/A | -9 | -8 | -8 | N/A |
6/30/2021 | 1 | -3 | -2 | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CVB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: CVB is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CVB is expected to become profitable in the next 3 years.
Revenue vs Market: CVB's revenue (48.5% per year) is forecast to grow faster than the Australian market (4.8% per year).
High Growth Revenue: CVB's revenue (48.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CVB is forecast to be unprofitable in 3 years.